Celio Geraldo Freire-de-Lima

Dr. Celio Geraldo Freire-de-Lima

Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-170, Brazil
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ACAna Caroline Costa-da-Silva
Ana Caroline Costa-da-Silva
DNDanielle de Oliveira Nascimento
Danielle de Oliveira Nascimento
JFJesuino Rafael Machado Ferreira
Jesuino Rafael Machado Ferreira
KPKamila Guimarães Pinto
Kamila Guimarães Pinto
Leonardo Freire-de-LimaLeonardo Freire-de-Lima
Leonardo Freire-de-Lima
Celio Geraldo Freire-de-LimaCelio Geraldo Freire-de-Lima
Celio Geraldo Freire-de-Lima
Leishmaniasis is a parasitic, widespread, and neglected disease that affects more than 90 countries in the world. More than 20 Leishmania species cause different forms of leishmaniasis that range in severity from cutaneous lesions to systemic infection. The diversity of leishmaniasis forms is due to the species of parasite, vector, environmental and social factors, genetic background, nutritional status, as well as immunocompetence of the host. Here, we discuss the role of the immune system, its molecules, and responses in the establishment, development, and outcome of Leishmaniasis, focusing on innate immune cells and Leishmania major interactions.

26 January 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JRJuliana D. B. Rocha
Juliana D. B. Rocha
MNMichelle T. C. Nascimento
Michelle T. C. Nascimento
DDDebora Decote-Ricardo
Debora Decote-Ricardo
SCSuzana Côrte-Real
Suzana Côrte-Real
AMAlexandre Morrot
Alexandre Morrot
Celio Geraldo Freire-de-LimaCelio Geraldo Freire-de-Lima
Celio Geraldo Freire-de-Lima
In the present study, we characterized the in vitro modulation of NETs (neutrophil extracellular traps) induced in human neutrophils by the opportunistic fungus Cryptococcus neoformans, evaluating the participation of capsular polysaccharides glucuronoxylomanan (GXM) and glucuronoxylomannogalactan (GXMGal) in this phenomenon. The mutant acapsular strain CAP67 and the capsular polysaccharide GXMGal induced NET production. In contrast, the wild-type strain and the major polysaccharide GXM did not induce NET release. In addition, C. neoformans and the capsular polysaccharide GXM inhibited PMA-induced NET release. Additionally, we observed that the NET-enriched supernatants induced through CAP67 yeasts showed fungicidal activity on the capsular strain, and neutrophil elastase, myeloperoxidase, collagenase and histones were the key components for the induction of NET fungicidal activity. The signaling pathways associated with NET induction through the CAP67 strain were dependent on reactive oxygen species (ROS) and peptidylarginine deiminase-4 (PAD-4). Neither polysaccharide induced ROS production however both molecules blocked the production of ROS through PMA-activated neutrophils. Taken together, the results demonstrate that C. neoformans and the capsular component GXM inhibit the production of NETs in human neutrophils. This mechanism indicates a potentially new and important modulation factor for this fungal pathogen.

30 January 2008 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
SVSuellen N. Villena
Suellen N. Villena
RPRoberta O. Pinheiro
Roberta O. Pinheiro
CPCarla S. Pinheiro
Carla S. Pinheiro
MNMarise P. Nunes
Marise P. Nunes
CTCristina M. Takiya
Cristina M. Takiya
Celio Geraldo Freire-de-LimaCelio Geraldo Freire-de-Lima
Celio Geraldo Freire-de-Lima
The effects of capsular polysaccharides, galactoxylomannan (GalXM) and glucuronoxylomannan (GXM), from acapsular (GXM negative) and encapsulate strains of Cryptococcus neoformans were investigated in RAW 264.7 and peritoneal macrophages. Here, we demonstrate that GalXM and GXM induced different cytokines profiles in RAW 264.7 macrophages. GalXM induced production of TNF‐α, NO and iNOS expression, while GXM predominantly induced TGF‐β secretion. Both GalXM and GXM induced early morphological changes identified as autophagy and late macrophages apoptosis mediated by Fas/FasL interaction, a previously unidentified mechanism of virulence. GalXM was more potent than GXM at induction of Fas/FasL expression and apoptosis on macrophages in vitro and in vivo. These findings uncover a mechanism by which capsular polysaccharides from C. neoformans might compromise host immune responses.

19 June 2019 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
DDDebora Decote-Ricardo
Debora Decote-Ricardo
ILIsabel Ferreira LaRocque-De-Freitas
Isabel Ferreira LaRocque-De-Freitas
JRJuliana Dutra B. Rocha
Juliana Dutra B. Rocha
DNDanielle O. Nascimento
Danielle O. Nascimento
MNMarise P. Nunes
Marise P. Nunes
Celio Geraldo Freire-de-LimaCelio Geraldo Freire-de-Lima
Celio Geraldo Freire-de-Lima
Cryptococcosis is a systemic fungal infection caused by Cryptococcus neoformans. In immunocompetent patients, cryptococcal infection is often confined to the lungs. In immunocompromised individuals, C. neoformans may cause life-threatening illness, either from novel exposure or through reactivation of a previously acquired latent infection. For example, cryptococcal meningitis is a severe clinical disease that can manifest in people that are immunocompromised due to AIDS. The major constituents of the Cryptococcus polysaccharide capsule, glucuronoxylomannan (GXM), and galactoxylomannan (GalXM), also known as glucuronoxylomanogalactan (GXMGal), are considered the primary virulence factors of Cryptococcus. Despite the predominance of GXM in the polysaccharide capsule, GalXM has more robust immunomodulatory effects on host cellular immunity. This review summarizes current knowledge regarding host-Crytococcus neoformans interactions and the role of capsular polysaccharides in host immunomodulation. Future studies will likely facilitate a better understanding of the mechanisms involved in antigenic recognition and host immune response to C. neoformans and lead to the development of new therapeutic pathways for cryptococcal infection.

1 January 2015 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
ANAna Flávia Nardy
Ana Flávia Nardy
Celio Geraldo Freire-de-LimaCelio Geraldo Freire-de-Lima
Celio Geraldo Freire-de-Lima
AMAlexandre Morrot
Alexandre Morrot
Microbes have evolved a diverse range of strategies to subvert the host immune system. The protozoan parasiteTrypanosoma cruzi, the causative agent of Chagas disease, provides a good example of such adaptations. This parasite targets a broad spectrum of host tissues including both peripheral and central lymphoid tissues. Rapid colonization of the host gives rise to a systemic acute response which the parasite must overcome. The parasite in fact undermines both innate and adaptive immunity. It interferes with the antigen presenting function of dendritic cells via an action on host sialic acid-binding Ig-like lectin receptors. These receptors also induce suppression of CD4+T cells responses, and we presented evidence that the sialylation of parasite-derived mucins is required for the inhibitory effects on CD4 T cells. In this review we highlight the major mechanisms used byTrypanosoma cruzito overcome host immunity and discuss the role of parasite colonization of the central thymic lymphoid tissue in chronic disease.

9 March 2016 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
ANAna Flávia Fernandes Ribas Nardy
Ana Flávia Fernandes Ribas Nardy
Leonardo Freire-de-LimaLeonardo Freire-de-Lima
Leonardo Freire-de-Lima
Celio Geraldo Freire-de-LimaCelio Geraldo Freire-de-Lima
Celio Geraldo Freire-de-Lima
AMAlexandre Morrot
Alexandre Morrot
Glycans are part of the essential components of a cell. These compounds play a fundamental role in several physiopathological processes including cell differentiation, adhesion, motility, signal transduction, host-pathogen interactions, tumor cell invasion and metastasis development. Glycans are also able to exert control over the changes in tumor immunogenecity, interfering with tumor editing events and leading to immune resistant cancer cells. The involvement of glycans in cancer progression are related to glycosylation alterations. Understanding such changes is, therefore, extremely useful to set the stage for their use as biomarkers, improving the diagnostics and therapeutic strategies. Herein, we discuss the basis of how modifications in glycosylation patterns may contribute to cancer genesis and progression as well as their importance in oncology field.